glp-1/gcgr dual agonist Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Evaluation of biased agonism mediated
Description
[DOI] [PubMed] [Google Scholar] 43.Urva S, Coskun T, Loh MT, Du Y, Thomas MK, Gurbuz S, et al
Questions for Cramer
GLP-1 medications were originally developed for type 2 diabetes , but are now also approved for people with obesity or weight-related health conditions
But it was scary."
Steinmetz, J
